Interferon gamma induced oncolysis. An effect on head and neck squamous carcinoma cultures

W J Richtsmeier1

  • 1Johns Hopkins Medical Institutions, Baltimore, MD 21205.

Insights

Recombinant human interferon gamma shows an oncolytic effect on squamous cell carcinoma (SCC) tissue cultures. This finding suggests potential new therapeutic strategies for SCC by utilizing interferon gamma for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Squamous cell carcinoma (SCC) is a common cancer.
  • Interferon gamma (IFN-γ) is a cytokine with known immune-modulating properties.
  • The direct oncolytic potential of recombinant human interferon gamma (rhIFN-γ) on SCC requires further elucidation.

Purpose of the Study:

  • To investigate the direct oncolytic effect of rhIFN-γ on various squamous cell carcinoma (SCC) tissue cultures.
  • To quantify the cellular changes induced by rhIFN-γ exposure in SCC models.
  • To determine the sensitivity of different SCC origins to rhIFN-γ mediated oncolysis.

Main Methods:

  • Utilized established SCC tissue cultures from head and neck mucosa, cervix, and skin.
  • Exposed cultures to rhIFN-γ and observed visual changes.
  • Quantified viable cell loss by measuring total cellular protein mass using naphthol blue-black dye staining.
  • Differentiated rhIFN-γ effects from tumor necrosis factor by using a single-gene cloned recombinant form.

Main Results:

  • rhIFN-γ demonstrated a measurable oncolytic effect on SCC tissue cultures.
  • Significant loss of total cellular protein was observed four days post-exposure, with visual changes noted after one day.
  • SCC cultures from head and neck, cervix, and skin exhibited sensitivity to rhIFN-γ.
  • Head and neck SCC cultures showed sensitivity at concentrations below 30 U/mL.

Conclusions:

  • Recombinant human interferon gamma possesses direct oncolytic activity against squamous cell carcinoma.
  • The timing of rhIFN-γ exposure is critical for achieving desired oncolytic effects in treatment regimens.
  • rhIFN-γ represents a potential therapeutic agent for treating various types of SCC.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...